menu
menu
Create an account
Log In
Donate
You're on VON's public site. To go to our logged in area, click
here
Who We Are
arrow_drop_down
About Us
Our Impact
Member Map and Member List
Case Studies
Newsletter
Directors and Advisors
Staff List
Contact Us
What We Do
arrow_drop_down
Overview
Databases and Reporting
Overview
Database Summaries
Quality Improvement and Education
Overview & All Programs
All Care is Brain Care
Collaborative Spotlight
QI Foundations
Responding to NAS
Grand Rounds
Institute for Evidence-Based Practice
Libraries
All VON Libraries
Health Equity
Publications
NICU by the Numbers
Cochrane at VON
Improvement Library
Tools
Manuals and Forms
eNICQ 6
Week 36 Calculator
Fahrenheit to Centigrade Conversion Table
Transfer Codes
Neonatal Drug Concentrations
Group Services
Global Health
Quality Congress
Join Us
arrow_drop_down
Membership Benefits & Tiers
Global Health
Membership FAQs
Follow Us On Social Media
search
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
Post navigation
Hydralazine in infants with persistent hypoxemic respiratory failure
Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung disease
